$6.17-0.15|(-2.37%)
52W H: 15.3752W L: 4.38Beta: -1.80

About CapsoVision Inc

Frequently Asked Questions

What is the 52-week range for CV?

The 52-week high is $15.37 and the 52-week low is $4.38.

What is the P/E ratio for CV?

The P/E ratio data is currently unavailable.

What is the dividend yield for CV?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is -177.85%.

What is the Net Profit Margin?

The Net Profit Margin (TTM) is -214.74%.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 37.76.

Analyst Recommendation Trends

Wall Street analyst consensus for CV over the last few months:

2026-09-01
Buy: 6
S.Buy: 3
Hold: 1
Sell: 0
2026-08-01
Buy: 5
S.Buy: 3
Hold: 1
Sell: 0
2026-07-01
Buy: 5
S.Buy: 3
Hold: 1
Sell: 0
2026-06-01
Buy: 5
S.Buy: 3
Hold: 1
Sell: 0

Latest CV News

CapsoVision Announces FDA Clearance of AI Highlights for CapsoCam Plus®

AI-assisted reading tool designed to aid physician review of small bowel capsule endoscopy studies performed due to suspected bleeding using the CapsoCam Plus® systemSARATOGA, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that AI Highlights™, its AI-assisted reading tool for the CapsoCam Plus system, received clearance from the U.S. Fo

Yahoo9/28/2026

CapsoVision Receives FDA Clearance For Its AI Highlights Reading Tool For The CapsoCam Plus System

AI Highlights is designed to support physicians in the review of small bowel capsule endoscopy studies collected from adult and pediatric patients (over two years of age) in whom the study was performed due to suspected

Benzinga9/28/2026

CapsoVision Announces Offering Of 3,163,444 Shares Of Common Stock At A Price Of $5.69/Share, Net Proceeds Expected At $17.83M

CapsoVision, Inc.3,163,444 Shares of Common Stock   We are offering 3,163,444 shares of our common stock, par value $0.001 per share, under this prospectus supplement directly to a number of investors (collectively, the

Benzinga9/18/2026

CapsoVision to Participate in Upcoming Investor Conferences

SARATOGA, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that Johnny Wang, President and Chief Executive Officer, David Garcia, Senior Vice President of Finance, and Doug Atkinson, Senior Vice President of Global Sales, plan to participate in the following upcoming investor conferences: H.C. Wainwright 28th Annual Global Investment Conf

Yahoo9/3/2026

Related Stocks (Peers)

Companies operating in similar sectors to CV:

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-09-18HARARI ELIYAHOU ET AL+878,734$5.69$4,999,996
2026-09-18HARARI ELIYAHOU ET AL+878,735$5.69$5,000,002
2026-09-15Shen Ching Hang+878,734$5.69$4,999,996
2026-09-15Shen Ching Hang+878,734$5.69$4,999,996
2026-07-17HARARI ELIYAHOU ET AL+61,068$6.73$410,988
2026-07-08HARARI ELIYAHOU ET AL+81,300$6.09$495,117
2026-07-01Shields David Stanley+1,710--
2026-06-30Imperial Joanne Carol-2,022--
2026-06-30Imperial Joanne Carol+2,022$7.58$15,327
2026-06-30Kuo Hui Ying-2,022--
2026-06-30Kuo Hui Ying+2,022$7.58$15,327
2026-06-30King Wen-Herng Henry-2,022--
2026-06-30King Wen-Herng Henry+2,022$7.58$15,327
2026-06-30Harari Michele-2,022--
2026-06-30Harari Michele+2,022$7.58$15,327
2026-06-30Tsai Chen Lung-2,022--
2026-06-30Tsai Chen Lung+2,022$7.58$15,327
2026-06-30GOUW JULIA S-2,022--
2026-06-30GOUW JULIA S+2,022$7.58$15,327
2026-06-26HARARI ELIYAHOU ET AL+13,850$7.351$101,811
2026-06-08Imperial Joanne Carol-1,200$7.1555$8,587
2026-06-01Garcia David Michael+92,212--
2026-06-01Wang Kang-Huai+358,344--
2026-06-01Atkinson Douglas Patrick+158,078--
2026-05-05Atkinson Douglas Patrick-34,786--
2026-05-05Atkinson Douglas Patrick+34,786$0.5661$19,692
2026-05-04Atkinson Douglas Patrick-6,505--
2026-05-04Atkinson Douglas Patrick-30,030--
2026-05-04Atkinson Douglas Patrick-36,036--
2026-05-04Atkinson Douglas Patrick+6,505$0.5661$3,682
2026-05-04Atkinson Douglas Patrick+30,030$0.3663$11,000
2026-05-04Atkinson Douglas Patrick+36,036$0.2863$10,317
2026-04-17Shen Ching Hang+3,991,606--
2026-04-17Shen Ching Hang-3,991,606--
2026-03-19Imperial Joanne Carol+4,045--
2026-03-19Kuo Hui Ying+4,045--
2026-03-19King Wen-Herng Henry+4,045--
2026-03-19Harari Michele+4,045--
2026-03-19Tsai Chen Lung+4,045--
2026-03-19GOUW JULIA S+4,045--
2025-12-31Imperial Joanne Carol-2,887--
2025-12-31Imperial Joanne Carol+2,887$10.69$30,862
2025-12-31Kuo Hui Ying-2,887--
2025-12-31Kuo Hui Ying+2,887$10.69$30,862
2025-12-31King Wen-Herng Henry-2,887--
2025-12-31King Wen-Herng Henry+2,887$10.69$30,862
2025-12-31Harari Michele-2,887--
2025-12-31Harari Michele+2,887$10.69$30,862
2025-12-31Tsai Chen Lung-2,887--
2025-12-31Tsai Chen Lung+2,887$10.69$30,862
2025-12-31GOUW JULIA S-2,887--
2025-12-31GOUW JULIA S+2,887$10.69$30,862
2025-11-03Garcia David Michael+165,000--